Earnings preview: What to expect from the Ramsay Health Care FY 2020 result

The Ramsay Health Care Limited (ASX:RHC) share price will be one to watch later this month when it releases its full year results…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price could be on the move later this month when it releases its results.

Ahead of the release of the private hospital operator's results on 27 August 2020, I thought I would look to see what analysts are expecting from the company.

What should you expect from Ramsay Health Care in FY 2020?

According to a note out of Goldman Sachs, its analysts believe Ramsay could fall short of the market's expectations later this month.

Its analysts are forecasting FY 2020 revenue of $12,021 million, up 3.6% on the prior corresponding period. However, this will be a touch short of the consensus estimate of $12,175 million.

Goldman doesn't expect this top line growth to flow through to its earnings. It has forecast earnings before interest, tax, depreciation, and amortisation (EBITDA) of $1,273 million. This will be a 20% decline on FY 2019's EBITDA and compares to the consensus estimate of $1,578 million.

And on the bottom line, the broker is forecasting earnings per share of $1.53 in FY 2020, which will be a 46% decline year on year. As a comparison, the market consensus estimate is for earnings per share of $1.63.

What about FY 2021?

Most investors have accepted that Ramsay's FY 2020 will be underwhelming because of the pandemic, so their focus will be on the year ahead.

Goldman Sachs is forecasting a 12% increase in revenue to $13,481.1 million in FY 2021. From this, it expects Ramsay's EBITDA to rebound 25% to $1,589.9 million. This means it will be back in line with its pre-pandemic levels.

Should you invest?

While Goldman only has a neutral rating and $63.00 price target on Ramsay's shares, I'm a little more bullish and would class them as a buy.

Just as long as you're prepared to make a patient long term investment. The near term may be difficult, but I believe it has a very positive long term outlook. Overall, I feel it could beat the market over the 2020s.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

12 ASX 200 shares that smashed historical peak prices today

Twelve ASX 200 shares rose to new multi-year peaks in an otherwise quiet day of trading.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors saw another day of mild gains for the stock market this Thursday.

Read more »

Two boats on the water with crates with the words trade war in the middle.
Share Market News

Trump's tariffs blocked by trade court: Which ASX 200 stocks could benefit the most?

These 3 ASX 200 stocks have heavy tariffs exposure.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Broker Notes

How this undervalued ASX All Ords share could rocket 80% in a year

A leading fund manager expects a big turnaround for this beaten-down ASX All Ords stock.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

These shares are having a good session today. But why are investors buying them?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why ALS, Black Cat, Boss Energy, and Soul Patts shares are falling today

These shares are falling on Thursday. Let's find out why.

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Broker Notes

Up 77% in a year, guess how much more upside Macquarie tips for Eagers Automotive shares

Macquarie released its latest analysis on Eagers Automotive fast rising shares this morning.

Read more »

Boy looks quizzical standing in front of a graph.
Share Market News

Big ASX 200 news! Stock market whipsaws as Trump's tariffs struck down

Markets initially surged on news that Trump's tariffs are out.

Read more »